ASX healthcare innovators target costly surgical complications and repeat procedures Posted on May 8, 2026May 8, 2026 by recce_com ASX healthcare innovators target costly surgical complications and repeat procedures
Recce clears regulatory inspection for Phase III DFI trial in Indonesia Posted on April 28, 2026 by recce_com Recce clears regulatory inspection for Phase III DFI trial in Indonesia
No more tears as Recce takes on antibiotic superbug crisis Posted on April 13, 2026 by recce_com No more tears as Recce takes on antibiotic superbug crisis
Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight Posted on April 7, 2026 by recce_com Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight
Biocurious: US military enlists Aussie biotechs in the germ warfare battle Posted on March 25, 2026 by recce_com Biocurious: US military enlists Aussie biotechs in the germ warfare battle
Recce lands Brazil patent as global anti-infectives footprint expands Posted on March 25, 2026March 25, 2026 by recce_com Recce lands Brazil patent as global anti-infectives footprint expands
The world is running out of antibiotics. New research could make old ones work again Posted on February 27, 2026 by recce_com The world is running out of antibiotics. New research could make old ones work again
US Army backs Recce’s synthetic antibiotic for burns Posted on February 10, 2026 by recce_com US Army backs Recce’s synthetic antibiotic for burns
Break it Down: Recce expands US Army research deals to fight deadly pathogens Posted on February 5, 2026 by recce_com Break it Down: Recce expands US Army research deals to fight deadly pathogens
Executive Edge: James Graham on Recce’s fight against superbugs Posted on February 5, 2026 by recce_com Executive Edge: James Graham on Recce’s fight against superbugs
